Investment research firm Susquehanna Financial initiated coverage of the Durect (DRRX)with a positive rating.....DRRX moved up 5.7% to $3.70 .......
AstraZeneca (AZN) was downgraded to a hold from a buy by
Citigroup......AZN shares were 1.3% lower to $61.35.
Citigroup also downgraded generic drugmaker Endo Pharmaceuticals (ENDP) from a buy rating to a hold...... with a price target of $34. Shares fell 1.4% to $31.24.
AstraZeneca (AZN) was downgraded to a hold from a buy by
Citigroup......AZN shares were 1.3% lower to $61.35.
Citigroup also downgraded generic drugmaker Endo Pharmaceuticals (ENDP) from a buy rating to a hold...... with a price target of $34. Shares fell 1.4% to $31.24.
posted by doublezero at
2:49 PM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home